Tendency of dynamic vasoactive and inotropic medications data as a robust predictor of mortality in patients with septic shock: An analysis of the MIMIC-IV database

Septic shock patients fundamentally require delicate vasoactive and inotropic agent administration, which could be quantitatively and objectively evaluated by the vasoactive–inotropic score (VIS); however, whether the dynamic trends of high-time-resolution VIS alter the clinical outcomes remains unclear. Thus, this study proposes the term VIS Reduction Rate (VRR) to generalise the tendency of dynamic VIS, to explore the association of VRR and mortality for patients with septic shock.We applied dynamic and static VIS data to predict ICU mortality by two models: the long short-term memory (LSTM) deep learning model, and the extreme gradient boosting (XGBoost), respectively. The specific target cohort was extracted from the Medical Information Mart for Intensive Care IV (MIMIC-IV) database by the sophisticated structured query language (SQL). Enrolled patients were divided into four groups by VRR value: ≥50%, 0 ~ 50%, −50% ~ 0, and < −50%. Statistical approaches included pairwise propensity score matching (PSM), Cox proportional hazards regression, and two doubly robust estimation models to ensure the robustness of the results. The primary and secondary outcomes were ICU mortality and in-hospital mortality, respectively.VRR simplifies the dosing trends of vasoactive and inotropic agents represented by dynamic VIS data while requiring fewer data. In total, 8,887 septic shock patients were included. Compared with the VRR ≥50% group, the 0 ~ 50%, −50% ~ 0, and < −50% groups had significantly higher ICU mortality [hazard ratio (HR) 1.32, 95% confidence interval (CI) 1.17–1.50, p < 0.001; HR 1.79, 95% CI 1.44–2.22, p < 0.001; HR 2.07, 95% CI 1.61–2.66, p < 0.001, respectively] and in-hospital mortality [HR 1.43, 95% CI 1.28–1.60, p < 0.001; HR 1.75, 95% CI 1.45–2.11, p < 0.001; HR 2.00, 95% CI 1.61–2.49, p < 0.001, respectively]. Similar findings were observed in two doubly robust estimation models.The trends of dynamic VIS in ICU might help intensivists to stratify the prognosis of adult patients with septic shock. A lower decline of VIS was remarkably associated with higher ICU and in-hospital mortality among septic shock patients receiving vasoactive–inotropic therapy for more than 24 h.

[1]  G. Geri,et al.  Vasopressors and Risk of Acute Mesenteric Ischemia: A Worldwide Pharmacovigilance Analysis and Comprehensive Literature Review , 2022, Frontiers in Medicine.

[2]  C. Sprung,et al.  Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 , 2021, Intensive Care Medicine.

[3]  R. Rameshkumar,et al.  Threshold of Inotropic Score and Vasoactive–Inotropic Score for Predicting Mortality in Pediatric Septic Shock , 2021, Indian Journal of Pediatrics.

[4]  S. Moon,et al.  Vasoactive-Inotropic Score as an Early Predictor of Mortality in Adult Patients with Sepsis , 2021, Journal of clinical medicine.

[5]  J. Gagne,et al.  Association of Fluoroquinolones With the Risk of Aortic Aneurysm or Aortic Dissection. , 2020, JAMA internal medicine.

[6]  James F. Gilmore,et al.  Evaluation of Vasopressor Exposure and Mortality in Patients With Septic Shock* , 2020, Critical care medicine.

[7]  E. Kattan,et al.  Optimal target in septic shock resuscitation , 2020, Annals of translational medicine.

[8]  Søren Brunak,et al.  Dynamic and explainable machine learning prediction of mortality in patients in the intensive care unit: a retrospective study of high-frequency data in electronic patient records. , 2020, The Lancet. Digital health.

[9]  K. Anger,et al.  Vasoactive Agents for Adult Septic Shock: An Update and Review , 2020, Journal of pharmacy practice.

[10]  S. Brunak,et al.  Survival prediction in intensive-care units based on aggregation of long-term disease history and acute physiology: a retrospective study of the Danish National Patient Registry and electronic patient records. , 2019, The Lancet. Digital health.

[11]  L. Forni,et al.  Broad spectrum vasopressors: a new approach to the initial management of septic shock? , 2019, Critical Care.

[12]  Timothy M. Koponen,et al.  Vasoactive‐inotropic score and the prediction of morbidity and mortality after cardiac surgery , 2019, British journal of anaesthesia.

[13]  Libing Jiang,et al.  The effects and safety of vasopressin receptor agonists in patients with septic shock: a meta-analysis and trial sequential analysis , 2019, Critical Care.

[14]  Rinaldo Bellomo,et al.  Intravenous fluid therapy in critically ill adults , 2018, Nature Reviews Nephrology.

[15]  Sergio L. Zanotti Cavazzoni,et al.  A global perspective on vasoactive agents in shock , 2018, Intensive Care Medicine.

[16]  Leo Anthony Celi,et al.  Transthoracic echocardiography and mortality in sepsis: analysis of the MIMIC-III database , 2018, Intensive Care Medicine.

[17]  S. Schneeweiss,et al.  Cardiovascular outcomes associated with canagliflozin versus other non-gliflozin antidiabetic drugs: population based cohort study , 2018, British Medical Journal.

[18]  K. Oba,et al.  Vasoactive-inotropic score as a predictor of morbidity and mortality in adults after cardiac surgery with cardiopulmonary bypass , 2018, Journal of Anesthesia.

[19]  J. Davidson,et al.  Validation of the Vasoactive-Inotropic Score in Pediatric Sepsis* , 2017, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

[20]  Scott Lundberg,et al.  A Unified Approach to Interpreting Model Predictions , 2017, NIPS.

[21]  Jun-bo Zheng,et al.  Clinical application of intra-aortic balloon pump in patients with cardiogenic shock during the perioperative period of cardiac surgery , 2017, Experimental and therapeutic medicine.

[22]  J. Marshall,et al.  Permissive hypotension during shock resuscitation: equipoise in all patients? , 2017, Intensive Care Medicine.

[23]  R. Hotchkiss,et al.  Sepsis and septic shock , 2016, Nature Reviews Disease Primers.

[24]  Tianqi Chen,et al.  XGBoost: A Scalable Tree Boosting System , 2016, KDD.

[25]  Shamim Nemati,et al.  Machine Learning and Decision Support in Critical Care , 2016, Proceedings of the IEEE.

[26]  S. Aggarwal,et al.  Vasoactive Inotropic Score (VIS) as Biomarker of Short-Term Outcomes in Adolescents after Cardiothoracic Surgery , 2016, Pediatric Cardiology.

[27]  S. Aggarwal,et al.  Vasoactive–inotropic score after pediatric heart transplant: A marker of adverse outcome , 2013, Pediatric transplantation.

[28]  Samuel M Brown,et al.  Survival after shock requiring high-dose vasopressor therapy. , 2013, Chest.

[29]  R. Thiagarajan,et al.  Vasoactive-inotropic score as a measure of pediatric cardiac surgical outcomes. , 2010, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

[30]  R. Ohye,et al.  Vasoactive–inotropic score as a predictor of morbidity and mortality in infants after cardiopulmonary bypass* , 2010, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

[31]  E. Ruokonen,et al.  Association of arterial blood pressure and vasopressor load with septic shock mortality: a post hoc analysis of a multicenter trial , 2009, Critical care.

[32]  Sangeeta Mehta,et al.  Vasopressin versus norepinephrine infusion in patients with septic shock. , 2008, The New England journal of medicine.

[33]  R. Dellinger,et al.  Hemodynamic optimization of sepsis-induced tissue hypoperfusion , 2006, Critical care.